Oncology & Cancer

A potential early esophageal cancer antigen: DDX53

A new research paper has been published in Oncoscience, titled "An immunoinformatics assessment of the cancer testis antigen, DDX53, as a potential early esophageal cancer antigen."

Immunology

Unveiling a novel immune response in the intestinal epithelium

Researchers from the Jan Dobeš laboratory at Charles University in Prague have made a significant discovery uncovering a novel immune response in the intestinal epithelium. Furthermore, their study delineates a mechanism ...

Diseases, Conditions, Syndromes

SARS-CoV-2 virus found to migrate within neurons and infect the brain

The emergence of different variants of SARS-CoV-2 has produced a wide range of clinical profiles and symptoms in patients. For the first time, researchers at the Institut Pasteur and Université Paris Cité have demonstrated, ...

Genetics

BabySeq 2.0: Bringing equity to genomic sequencing in newborns

Today, nearly 900 disorders caused by a single gene are known to be treatable. Yet the recommended "heel stick" testing for newborns only covers about 60 inherited, treatable disorders, and many individual states screen for ...

Medical research

Bat genes found to be key against COVID, cancer

Bats have acquired remarkable traits throughout their evolution. They're the only mammals that can fly, and they live much longer than other animals their size. But perhaps most impressive is their robust immune system. It ...

Neuroscience

New biomarker predicts whether neurons will regenerate

Neurons, the main cells that make up our brain and spinal cord, are among the slowest cells to regenerate after an injury, and many neurons fail to regenerate entirely. While scientists have made progress in understanding ...

page 7 from 40